MedTrace Logo

Dual Energy Cardiac CT Data Collection and Evaluation

NCT05171764 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-12-18

No results posted yet for this study

Summary

This study is intended to collect clinical feasibility data using this prototype research mode for the purposes of understanding potential clinical impact, potential limitations and strengths, and to further develop the technique through development of image reconstruction and processing approaches or identification of other areas of development required.

Conditions

Interventions

DEVICE

Additional Gemstone Spectral Imaging (GSI) cardiac scan

After the subject undergoes the clinically prescribed cardiac Computed Tomography (CT) scan for their diagnostic purposes, the investigational Gemstone Spectral Imaging (GSI) scan will be conducted following the diagnostic CT scan utilizing the same contrast administration.

Sponsors & Collaborators

  • University Hospital, Zürich

    collaborator OTHER

  • GE Healthcare

    lead INDUSTRY

Principal Investigators

  • Melissa Challman · GE Healthcare

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-14
Primary Completion
2023-10-13
Completion
2023-10-13
FDA Device
Yes

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05171764 on ClinicalTrials.gov